Fibromyalgia-related costs and loss of productivity: a substantial societal burden
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study aimed at describing pain-related health care resource use, direct costs, and productivity loss among patients suffering from fibromyalgia syndrome (FMS). METHODS: A cost-of-illness study with a sample of 57 adults having a diagnosis of FMS was conducted in the province of Quebec (Canada). Data regarding FMS-related direct costs and productivity loss from paid and unpaid work over a three-month period were collected using a standardized structured telephone interview protocol. Direct costs were valued in 2009 Canadian dollars using a societal perspective. RESULTS: Results showed that average direct costs over a three-month period added up to $951 per patient (SD: $710), which could be translated in a mean annual cost of $3804. The purchase of prescribed medications led to the highest costs (mean: $329, SD: $321), followed by consultations to health care professionals other than physicians (mean: $129, SD: $222) and physicians consultations (mean: $98, SD: $116). Results further showed a high economic burden for patients themselves, aside from costs covered by public or private insurers. Among the subsample of participants who had a paid job (45.6%), an average of 5.6 days (SD: 13.2) were lost due to pain during the past three months. Among those who were not employed (54.4%), an average of 25.1 days in household productivity (SD: 24.8) were lost. CONCLUSIONS: FMS is associated with a substantial socioeconomic burden. Further research is clearly needed to improve the management of this type of disorder and make better decisions regarding resource allocation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 1×
“Background Fibromyalgia syndrome (FMS) is a chronic disorder with key symptoms such as chronic widespread musculoskeletal pain, sleep disturbances, cognitive dysfunctions, mood disturbances and fatigue [1].”
Prevalence of Fibromyalgia: A Survey in Five European Countries
Branco, J. C., Bannwarth, B., Failde, I., Abello Carbonell, J., Blotman, F., Spaeth, M., Saraiva, F., Nacci, F., Thomas, E., Caubère, J.-P., et al. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.12.003 · Cited by 685
Fitzcharles, M.-A., Ste-Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Choinière, M., Ko, G., Moulin, D. E., Panopalis, P., Proulx, J., et al. (2013) · Pain Research and Management · doi:10.1155/2013/918216 · Cited by 409
Self-citationBoonen, A., van den Heuvel, R., van Tubergen, A., Goossens, M., Severens, J. L., van der Heijde, D., & van der Linden, S. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019711 · Cited by 219 · cited 1×
“Many other studies found a heavier economic burden of FMS compared with other disorders or healthy subjects [17, 19, 20, 23, 26, 28, 29, 31, 34, 35] while others studies have not found significant differences [18, 33, 36].”
Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss
White, L. A., Birnbaum, H. G., Kaltenboeck, A., Tang, J., Mallett, D., & Robinson, R. L. (2008) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e31815cff4b · Cited by 168
Burden of fibromyalgia and comparisons with osteoarthritis in the workforce
Kleinman, N., Harnett, J., Melkonian, A., Lynch, W., Kaplan-Machlis, B., & Silverman, S. L. (2009) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181bb808b · Cited by 62 · cited 1×
“Many other studies found a heavier economic burden of FMS compared with other disorders or healthy subjects [17, 19, 20, 23, 26, 28, 29, 31, 34, 35] while others studies have not found significant differences [18, 33, 36].”
Cited by
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
AAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M.-A., Paiva, E. S., Staud, R., Sarzi-Puttini, P., et al. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 420
Galvez-Sánchez, C. M., Montoro, C. I., Moreno-Padilla, M., Reyes del Paso, G. A., & de la Coba, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122706 · Cited by 45
Terpstra, J. A., van der Vaart, R., Ding, H. J., Kloppenburg, M., & Evers, A. W. M. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100444 · Cited by 19
“…overview will clarify what the specific benefit of guided iCBT is for this group of patients with an especially high disease burden (Berger et al., 2007; De Achaval and Suarez-Almazor, 2010; Evers et al., 2011; Hresko et al., 2018; Lacasse et al., 2016; Sturgeon et al., 2016; Yelin et al., 2007).”
BackgroundMukhida, K., Carroll, W., & Arseneault, R. (2020) · Canadian Journal of Pain · doi:10.1080/24740527.2020.1820858 · Cited by 19
Metadata
- Authors
- Lacasse, A., Bourgault, P., & Choinière, M.
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2016-04-16
- Volume
- 17
- Issue
- 1
- Pages
- 168-168
- ISSN
- 1471-2474 (ISSN-L)
- OpenAlex
- W2342294572
- Cited by
- 112
- References
- 7
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibromyalgia-related costs and loss of productivity: a substantial societal burden. https://app.cochat.ai/papers/10.1186/s12891-016-1027-6
- The paper
- Lacasse, A., Bourgault, P., & Choinière, M. (2016). Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskeletal Disorders. https://doi.org/10.1186/s12891-016-1027-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.